Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Garry

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
NPJ Vaccines|May 3, 2026
Searching for immune correlates in Lassa vaccine development - workshop reportTrevor Brasel, Polina Brangel, Ifedayo Adetifa, et al.
Scientific Reports|April 14, 2018
Field validation of recombinant antigen immunoassays for diagnosis of Lassa feverMatthew L Boisen, Jessica N Hartnett, Jeffrey G Shaffer, et al.
Scientific Reports|May 28, 2020
Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreakMatthew L Boisen, Eghosa Uyigue, John Aiyepada, et al.
Viruses|November 26, 2014
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014Jens H Kuhn, Kristian G Andersen, Sylvain Baize, et al.
Viruses|November 27, 2021
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra LeoneansRodrigo Borrega, Diana K S Nelson, Anatoliy P Koval, et al.
The New England Journal of Medicine|October 30, 2014
Clinical illness and outcomes in patients with Ebola in Sierra LeoneJohn S Schieffelin, Jeffrey G Shaffer, Augustine Goba, et al.
Scientific Reports|September 30, 2020
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineagesMegan L Heinrich, Matthew L Boisen, Diana K S Nelson, et al.
The New England Journal of Medicine|October 18, 2018
Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018Katherine J Siddle, Philomena Eromon, Kayla G Barnes, et al.
Cell|September 11, 2021
Emergence of an early SARS-CoV-2 epidemic in the United StatesMark Zeller, Karthik Gangavarapu, Catelyn Anderson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Emergence of an early SARS-CoV-2 epidemic in the United StatesMark Zeller, Karthik Gangavarapu, Catelyn Anderson, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
NPJ Vaccines|May 3, 2026
Searching for immune correlates in Lassa vaccine development - workshop reportTrevor Brasel, Polina Brangel, Ifedayo Adetifa, et al.
Scientific Reports|April 14, 2018
Field validation of recombinant antigen immunoassays for diagnosis of Lassa feverMatthew L Boisen, Jessica N Hartnett, Jeffrey G Shaffer, et al.
Scientific Reports|May 28, 2020
Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreakMatthew L Boisen, Eghosa Uyigue, John Aiyepada, et al.
Viruses|November 26, 2014
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014Jens H Kuhn, Kristian G Andersen, Sylvain Baize, et al.
Viruses|November 27, 2021
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra LeoneansRodrigo Borrega, Diana K S Nelson, Anatoliy P Koval, et al.
The New England Journal of Medicine|October 30, 2014
Clinical illness and outcomes in patients with Ebola in Sierra LeoneJohn S Schieffelin, Jeffrey G Shaffer, Augustine Goba, et al.
Scientific Reports|September 30, 2020
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineagesMegan L Heinrich, Matthew L Boisen, Diana K S Nelson, et al.
The New England Journal of Medicine|October 18, 2018
Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018Katherine J Siddle, Philomena Eromon, Kayla G Barnes, et al.
Cell|September 11, 2021
Emergence of an early SARS-CoV-2 epidemic in the United StatesMark Zeller, Karthik Gangavarapu, Catelyn Anderson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Emergence of an early SARS-CoV-2 epidemic in the United StatesMark Zeller, Karthik Gangavarapu, Catelyn Anderson, et al.
Pageof 21